Compounds > losartan

losartan and n-methylaspartate

losartan has been researched along with n-methylaspartate in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berrino, L; D'Amico, M; Maione, S; Oliva, P; Pizzirusso, A; Rossi, F1
Ferguson, P; Grammatopoulos, T; Jing, G; Schelman, W; Weyhenmeyer, J1
Andres, R; Ferguson, P; Kang, E; Orr, B; Schelman, WR; Weyhenmeyer, JA1
Kleiber, AC; Patel, KP; Sharma, NM; Zheng, H1
Liu, X; Llewellyn, T; Patel, KP; Xu, B; Zheng, H1

Other Studies

5 other study(ies) available for losartan and n-methylaspartate

ArticleYear
Role of vasopressin on excitatory amino acids mediated pressor responses in the periaqueductal gray area.
    Naunyn-Schmiedeberg's archives of pharmacology, 1998, Volume: 357, Issue:5

    Topics: Acetylcholine; Animals; Arginine Vasopressin; Blood Pressure; Ganglionic Blockers; Glutamic Acid; Hexamethonium; Losartan; Male; N-Methylaspartate; Periaqueductal Gray; Rats; Rats, Brattleboro

1998
Inhibitory effects of angiotensin on NMDA-induced cytotoxicity in primary neuronal cultures.
    Brain research bulletin, 2004, Feb-01, Volume: 62, Issue:5

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Brain; Cells, Cultured; Dose-Response Relationship, Drug; Glutamic Acid; In Situ Nick-End Labeling; Losartan; Mice; N-Methylaspartate; Neurons; Neuroprotective Agents

2004
Angiotensin II attenuates NMDA receptor-mediated neuronal cell death and prevents the associated reduction in Bcl-2 expression.
    Brain research. Molecular brain research, 2004, Sep-10, Volume: 128, Issue:1

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Death; Cell Line; Cell Survival; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Imidazoles; Losartan; N-Methylaspartate; Neurons; Proto-Oncogene Proteins c-bcl-2; Pyridines; Receptors, Angiotensin; Receptors, N-Methyl-D-Aspartate; Vasoconstrictor Agents

2004
Chronic AT1 receptor blockade normalizes NMDA-mediated changes in renal sympathetic nerve activity and NR1 expression within the PVN in rats with heart failure.
    American journal of physiology. Heart and circulatory physiology, 2010, Volume: 298, Issue:5

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blotting, Western; Cell Line, Tumor; Dose-Response Relationship, Drug; Glyceraldehyde-3-Phosphate Dehydrogenases; Heart Failure; Hemodynamics; Kidney; Losartan; Male; Microinjections; N-Methylaspartate; Neurons; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sympathetic Nervous System

2010
Median preoptic nucleus and subfornical organ drive renal sympathetic nerve activity via a glutamatergic mechanism within the paraventricular nucleus.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2012, Feb-15, Volume: 302, Issue:4

    Topics: 2-Amino-5-phosphonovalerate; Angiotensin II Type 1 Receptor Blockers; Animals; Bicuculline; Blood Pressure; Excitatory Amino Acid Antagonists; GABA-A Receptor Antagonists; Glutamic Acid; Heart Rate; Kidney; Losartan; Male; N-Methylaspartate; Neurons; Paraventricular Hypothalamic Nucleus; Preoptic Area; Rats; Rats, Sprague-Dawley; Subfornical Organ; Sympathetic Nervous System

2012